The World Health Organization (WHO) on Thursday issued an emergency use listing for the single-dose COVID-19 vaccine from China-based CanSino Biologics.
The vaccine, Convidecia, is the eleventh shot against the coronavirus to get clearance from the global health agency, whose advisory group recommended its use in people of age 18 years and above.
It was found to have 64 per cent efficacy against symptomatic disease and 92 per cent against severe COVID-19, the agency said.
Other vaccines that have similar clearance from the agency include those made by Pfizer and BioNTech, Moderna, AstraZeneca, Johnson & Johnson and Novavax.
Americans mark 25 years since September 11 attacks amid grief, reflection
Nigeria parliament boycotts South Africa events over anti-migrant attacks
Sydney Airport flights disrupted due to air traffic controller shortage
Philippine firefighters enter charred ferry as search continues for dozens missing
Modi, Putin hold talks in New Delhi on trade, defence
